Arab Drug reports higher profit in FY 2020/2021
Updated 7/29/2021 4:38:00 PM
ArabFinance: The Arab Drug Company (ADCI) posted a net profit of EGP 102.063 million in the fiscal year (FY) 2020/2021, according to the company’s financial statements filed to the Egyptian Exchange.
This marked a Year on Year (YoY) rise of 110% when compared to EGP 92.800 million in FY 2019/2020.
In FY 2021/2022, ADCI is targeting a net profit of EGP 116.3 million and has allocated EGP 129.7 million for the year's investments.
Arab Drug is an Egypt-based company engaged in the pharmaceutical sector. The company focuses on the manufacture, packaging, and distribution of pharmaceutical products as well as chemical solutions for human and veterinary use.
